MedPath

Effects of tDCS and TUS on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain

Active, not recruiting
Conditions
Chronic Pain
Chronic Low Back Pain
Interventions
Device: transcranial Direct Current Stimulation (tDCS)
Device: Transcranial Ultrasound (TUS)
Registration Number
NCT02954432
Lead Sponsor
Spaulding Rehabilitation Hospital
Brief Summary

The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain and functional limitations in subjects with NSCLBP. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Able to provide informed consent to participate in the study
  2. Subjects between 18 to 85 years old
  3. Subjects having non-specific chronic low back pain with existing pain for at least 3 months and having pain on at least half the days in the past 6 months with an average of at least 3 on a 0-10 visual analog scale (VAS) scale
  4. Pain resistant (partial or no response) to common analgesics and medications for chronic pain used as initial pain management such as Tylenol, Aspirin, Ibuprofen, Soma, Parafon Forte DCS, Zanaflex, and Codeine.
  5. Must have the ability to feel sensation by Von-Frey fiber on the forearm
Exclusion Criteria
  1. Subject is pregnant
  2. Contraindications to tDCS in conjunction with TUS, i.e. metallic implant in the brain or implanted brain medical devices
  3. History of alcohol or drug abuse within the past 6 months as self reported
  4. Use of carbamazepine within the past 6 months as self reported
  5. Suffering from severe depression (with a score of >30 in the Beck Depression Inventory)
  6. History of neurological disorders as self reported
  7. History of unexplained fainting spells as self reported
  8. History of severe head injury resulting in more than a momentary loss of consciousness as self reported
  9. History of neurosurgery as self reported
  10. Unstable pain
  11. Large placebo responder
  12. Low adherence during the run-in period
  13. Low baseline pain

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active tDCS + Active TUSTranscranial Ultrasound (TUS)Subjects in the experimental group will undergo 20 minutes of active transcranial direct current stimulation (tDCS) and active transcranial ultrasound (TUS).
Sham tDCS + Sham TUStranscranial Direct Current Stimulation (tDCS)Subjects in the sham group will undergo 20 minutes of sham transcranial direct current stimulation (tDCS) and sham transcranial ultrasound (TUS).
Active tDCS + Active TUStranscranial Direct Current Stimulation (tDCS)Subjects in the experimental group will undergo 20 minutes of active transcranial direct current stimulation (tDCS) and active transcranial ultrasound (TUS).
Sham tDCS + Sham TUSTranscranial Ultrasound (TUS)Subjects in the sham group will undergo 20 minutes of sham transcranial direct current stimulation (tDCS) and sham transcranial ultrasound (TUS).
Primary Outcome Measures
NameTimeMethod
Changes in Conditional Pain Modulation (Hand)Baseline and 3.5 months

Changes in Conditional Pain Modulation (CPM) will be measured in the hand in order to determine whether anodal transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) is effective in increasing the pain pressure threshold in subjects with non-specific chronic low back pain.

Changes in Mechanical Temporal Summation (Hand)Baseline and 3.5 months

Changes in Mechanical Temporal Summation (TS) from hand will be measured in order to determine whether anodal transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) is effective in reducing pain of subjects with non-specific chronic low back pain.

Changes in PainBaseline and 3.5 months

Changes in the Visual Analogue Scale (VAS) for pain will be measured in order to measure any changes in pain levels when subjects come in for sessions.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Spaulding Rehabilitation Network Research Institute

🇺🇸

Cambridge, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath